Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-632-3 | CAS number: 4432-31-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- expert statement
- Type of information:
- other: expert statement
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: expert statement based on physical/chemical and toxicology properties, no study on toxicokinetics available
- Principles of method if other than guideline:
- Expert statement
- GLP compliance:
- no
- Details on absorption:
- Generally, oral absorption is favoured for molecular weights below 500 g/mol. The high water solubility of 185 g/L for the test substance enables it to dissolve in the gastrointestinal fluids. In combination with the low molecular weight of 195 g/mol the substance can possibly pass through aqueous pores or can be carried through the epithelial barrier by the bulk passage of water. The low log Pow value of the test substance indicates that passive diffusion is less likely. Taken together, the physiochemical properties indicate that the test substance becomes bioavailable following the oral route.
Due to the melting point of the substance above 70 °C, no availability as a vapour under standard environmental conditions is expected. Still the vapour pressure was determined and is very low. It was calculated to be 1.39*10-4 Pa at 25 °C. As the substance is a powder formation and inhalation of dusts might occur. Generally particles with an aerodynamic diameter below 100 μm have the potential to be inspired, below 50 μm may reach the thoracic region and those below 15 μm can pass into the alveolar region of the respiratory tract. The test substance consists of only ca. 31 % particles smaller or equal to 100 μm (ca. 7 % smaller than 15 μm and ca. 20 % below 50 μm). As demonstrated by the distribution of the particle size the inhalable amount of the test substance is low and less than 10 % of the substance’s particles might possess the ability to reach the alveolar region. Deposited substance can potentially passage through aqueous pores or be carried across membranes with the bulk passage of water, while passive diffusion is less likely due to the low log Pow determined for both substances.
As a powder, the substance is not readily taken up by the skin. However, once moistened on the skin surface, absorption is possible, due to the high water solubility determined for the test substance. The molecular weight of the substance neither favours nor excludes dermal uptake. Considering the low log Pow of -2.2 of the test substance, the substance is likely to be too lipophobic to cross the stratum corneum, resulting in low absorption. - Details on distribution in tissues:
- As mentioned above, the physicochemical properties of the test substance favour systemic absorption following oral, inhalative and dermal uptake to a certain extent.
Direct transport through aqueous pores is likely to be an entry route to the systemic circulation. After being absorbed into the body, the substance is most likely not distributed into the interior part of cells due to the hydrophilic properties (log Pow -2.2) and in turn the extracellular concentration is expected to be higher than intracellular concentration.
The test substance does not have a bioaccumulative potential. The log Pow of the test substance indicates no bioaccumulation potential, as it is well below 3. - Details on excretion:
- Most of the test substance will be excreted most likely in its unhydrolised but possibly metabolised forms.
The most prominent excretion pathway of the substance is via urine, as substances with a molecular weight below 300 g/mol and with high water solubility are prone for this pathway.
Scientific data also supports the excretion via urine as morpholine, a defining group of the substance, was observed to be excreted by this pathway (Sohn 1982). However, the extent of metabolized forms compared to non-metabolised forms varied depending on species (Sohn 1982). - Details on metabolites:
- The genotoxicity studies with the test substance indicate no remarkable differences in regard to genotoxicity and cytotoxicity in the presence or absence of metabolic activation systems. Thus, no metabolic activation is expected. Generally it is likely that common protein interaction such as cytochrome P450 oxidases interaction during Phase I metabolism introduce a reactive or polar group in the substance. The oxidation and dehydrogenation are likely first steps of metabolic changes in the morpholine ring, followed by ring-opening.The involvement of cytochrome P450 is also supported by scientific data showing that the morpholine ring, the most defining group of the test substance, can be metabolized by cytochrome P450 starting with the C-N bond cleavage (Combourieu 2000). The resulting compounds might be further processed into polar compounds during the metabolism in Phase II.
- Conclusions:
- Bioaccumulation of the test substance is not considered critical based on an expert statement.
- Executive summary:
Based on physicochemical characteristics, particularly water solubility, molecular weight and octanol-water partition coefficient, systemic absorption following oral, inhalative and dermal uptake is favoured to a certain extent. Bioaccumulation of the test substance is not considered critical, as log Pow of the test substance indicates no bioaccumulation potential. Phase I and II metabolism within liver cells with involvement of cytochrome P450 is likely and excretion will presumably occur after renal passage via urine.
Reference
Description of key information
Based on physicochemical characteristics, particularly water solubility, molecular weight and octanol-water partition coefficient, systemic absorption following oral, inhalative and dermal uptake is favoured to a certain extent. Bioaccumulation of the test substance is not considered critical, as log Pow of the test substance indicates no bioaccumulation potential. Phase I and II metabolism within liver cells with involvement of cytochrome P450 is likely and excretion will presumably occur after renal passage via urine.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Toxicokinetic assessment
The test substance is a white solid at room temperature with a molecular weight of 195 g/mol. The substance is soluble in water (185 mg/L at 20 °C). The log Pow was determined to be -2.2. The test substance has a very low vapour pressure of 1.39*10^-4 Pa at 25 °C. The test substance is a mono-constituent substance. As no experimental data on absorption, distribution and excretion is available for both source and target substance, the toxicokinetic assessment is based on physicochemical properties of the substances and existing toxicological data.
Absorption
Generally, oral absorption is favoured for molecular weights below 500 g/mol. The high water solubility of 185 g/L for the test substance enables it to dissolve in the gastrointestinal fluids. In combination with the low molecular weight of 195 g/mol the substance can possibly pass through aqueous pores or can be carried through the epithelial barrier by the bulk passage of water. The low log Pow value of the test substance indicates that passive diffusion is less likely. Taken together, the physiochemical properties indicate that the test substance becomes bioavailable following the oral route.
Due to the melting point of the substance above 70 °C, no availability as a vapour under standard environmental conditions is expected. Still the vapour pressure was determined and is very low. It was calculated to be 1.39*10-4 Pa at 25 °C. As the substance is a powder formation and inhalation of dusts might occur. Generally particles with an aerodynamic diameter below 100 μm have the potential to be inspired, below 50 μm may reach the thoracic region and those below 15 μm can pass into the alveolar region of the respiratory tract. The test substance consists of only ca. 31 % particles smaller or equal to 100 μm (ca. 7 % smaller than 15 μm and ca. 20 % below 50 μm). As demonstrated by the distribution of the particle size the inhalable amount of the test substance is low and less than 10 % of the substance’s particles might possess the ability to reach the alveolar region. Deposited substance can potentially passage through aqueous pores or be carried across membranes with the bulk passage of water, while passive diffusion is less likely due to the low log Pow determined for both substances.
As a powder, the substance is not readily taken up by the skin. However, once moistened on the skin surface, absorption is possible, due to the high water solubility determined for the test substance. The molecular weight of the substance neither favours nor excludes dermal uptake. Considering the low log Pow of -2.2 of the test substance, the substance is likely to be too lipophobic to cross the stratum corneum, resulting in low absorption.
Distribution
As mentioned above, the physicochemical properties of the test substance favour systemic absorption following oral, inhalative and dermal uptake to a certain extent.
Direct transport through aqueous pores is likely to be an entry route to the systemic circulation. After being absorbed into the body, the substance is most likely not distributed into the interior part of cells due to the hydrophilic properties (log Pow -2.2) and in turn the extracellular concentration is expected to be higher than intracellular concentration.
The test substance does not have a bioaccumulative potential. The log Pow of the test substance indicates no bioaccumulation potential, as it is well below 3.
Metabolism
The genotoxicity studies with the test substance indicate no remarkable differences in regard to genotoxicity and cytotoxicity in the presence or absence of metabolic activation systems. Thus, no metabolic activation is expected. Generally it is likely that common protein interaction such as cytochrome P450 oxidases interaction during Phase I metabolism introduce a reactive or polar group in the substance. The oxidation and dehydrogenation are likely first steps of metabolic changes in the morpholine ring, followed by ring-opening.The involvement of cytochrome P450 is also supported by scientific data showing that the morpholine ring, the most defining group of the test substance, can be metabolized by cytochrome P450 starting with the C-N bond cleavage (Combourieu 2000). The resulting compounds might be further processed into polar compounds during the metabolism in Phase II.
Excretion
Most of the test substance will be excreted most likely in its unhydrolised but possibly metabolised forms.
The most prominent excretion pathway of the substance is via urine, as substances with a molecular weight below 300 g/mol and with high water solubility are prone for this pathway.
Scientific data also supports the excretion via urine as morpholine, a defining group of the substance, was observed to be excreted by this pathway (Sohn 1982). However, the extent of metabolized forms compared to non-metabolised forms varied depending on species (Sohn 1982).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.